Covid-19. Covid-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: Patients will receive Remdesivir and standard care. this group will receive 200 mg of Remdesivir IV for firs day and 100 mg daily for 4 days plus standard care acc
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Blood oxygen saturation<93% in room air or patients with patients in need of supportive oxygen or ventilation or Patients with pulmonary infiltration in radiological studies
Exclusion criteria
Exclusion criteria: Alanine aminotransferase and Aspartate aminotransferase rising more than 5 times the upper limit of normal Glomerular filtration rate less than 30ml/minute(according to Cockroft-Gault formula)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality or discharge. Timepoint: End of hospitalization period. Method of measurement: Patient file.;Hospitalization period. Timepoint: Hospitalization to discharge period. Method of measurement: Patient file.;ICU admission. Timepoint: From Hospitalization to discharge. Method of measurement: Patient file.;Clinical symptoms. Timepoint: From hospitalization to discharge. Method of measurement: Interview and examination.;Laboratory data. Timepoint: From hospitalization to discharge. Method of measurement: Laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Reisi
Shahre-kord University of Medical Sciences
Outcome results
None listed